Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: Real-world experience from a large comprehensive treatment centre in the US.

Lewandowska, Magdalena; Randall, Nicole; Bakeer, Nihal; Maahs, Jennifer; Sagar, Jeanne; Greist, Anne; Shapiro, Amy D

Lewandowska, Magdalena; Randall, Nicole; Bakeer, Nihal; Maahs, Jennifer; Sagar, Jeanne; Greist, Anne; Shapiro, Amy D.

Afiliación

Lewandowska M; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
Randall N; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
Bakeer N; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
Maahs J; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
Sagar J; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
Greist A; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
Shapiro AD; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.

Haemophilia ; 27(1): 90-99, 2021 Jan.

Article en En | MEDLINE | ID: mdl-33245841

Asunto(s)

Anticuerpos Biespecíficos; Hemofilia A; Anticuerpos Biespecíficos/uso terapéutico; Anticuerpos Monoclonales Humanizados/uso terapéutico; Factores de Coagulación Sanguínea; Factor VIII/uso terapéutico; Hemofilia A/complicaciones; Hemofilia A/tratamiento farmacológico; Humanos

Palabras clave

emicizumab; haemophilia; real-world evidence; surgery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Hemofilia A Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google